Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation.
Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.
A Top 40 of the more than 140 listed companies is constantly monitored for clinical development and price sensitive announcements and published via direct subscription.
Subscriptions are $A1750 a year (including GST in Australia).
Subscribers include biotech directors, CEOs and CFOs, research institutes, investment houses, market analysts, legal and IP specialists, medical specialists and hospital management.
Please fill in the subscription form below.
Payment Can be made by electronic transfer to:
A/c name Biotech Daily
A/c Number: 122-045-90
Please ensure your company name/ ASX code is in the reference line.